MedPath

Effectiveness of Bupivacaine After Laparoscopic Cholecystectomy

Not Applicable
Completed
Conditions
Postoperative Pain
Registration Number
NCT00599144
Lead Sponsor
Santa Maria alla Gruccia Hospital
Brief Summary

Evaluate the efficacy on postoperative pain of the positioning of a 0,5% bupivacaine soaked-tabotamp in gallbladder bed after videolaparoscopic cholecystectomy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Age>18 years old, ASA 1 and 2
  • Gallbladder adenomatous polyposis and cholelithiasis with no byochemical, clinical and instrumental evidence of acute cholecystitis at the moment of surgery.
Exclusion Criteria
  • Age<18 years old
  • Pregnancy
  • Previous major surgery of the supramesocholic compartment
  • Acute cholecystitis
  • Choledocolitiasis
  • Acute pancreatitis at the moment of surgery
  • Laparotomic conversion during surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Pain at 6 and 24 hours after surgery measured using the Visual Analogue Scale [VAS] [score 0 to 10, 0 = no pain, 10 = unbearable pain],6 and 24 hours after surgery
Secondary Outcome Measures
NameTimeMethod
Use of analgesics, extension of postsurgery hospitalization, post operative nausea and vomiting.6 and 24 hours

Trial Locations

Locations (1)

Ospedale santa maria alla gruccia

🇮🇹

Montevarchi, Ar, Italy

Ospedale santa maria alla gruccia
🇮🇹Montevarchi, Ar, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.